Project information
BEATSEP Biomarkers established to stratify sepsis long-term adverse effects to improve patients’ health and quality of life d to stratify sepsis long-term adverse effects to improve patients’ health and quality of life
(BEATsep)
- Project Identification
- 0745/2023
- Project Period
- 1/2024 - 12/2028
- Investor / Pogramme / Project type
-
European Union
- Horizon Europe
- Cluster 1 - Health
- MU Faculty or unit
-
Faculty of Medicine
- MUDr. Lukáš Homola, Ph.D.
- Ivana Blahová
- Mgr. Gabriela Fialová
- Miloslava Gambová
- Ing. MUDr. Patrícia Klobušiaková, Ph.D.
- MUDr. Žaneta Kocurová
- MUDr. Marek Kovář, EDIC
- Mgr. Sylvie Kropáčová, Ph.D.
- MUDr. Peter Mikolášek
- MUDr. Barbora Nebenführová
- MUDr. Jan Pavelka
- Mgr. Markéta Říhová, MBA
- Dr. Michal Pawel Santocki, PhD
- MUDr. Marie Slunská
- Marie Šindelářová
- prof. MUDr. Petr Štourač, Ph.D., MBA, LL.M., FESAIC
- Cooperating Organization
-
St. Anne's University Hospital Brno
- Responsible person Mgr. Jan Frič, Ph.D., MHA
- Responsible person Ing. Martin Liška
- Responsible person Mgr. Marcela Hortová Kohoutková, Ph.D.
State Institute of Healthcare Prague - Vinohrady
Comenius University in Bratislava
National Center for Scientific Research
UNIVERSITATSKLINIKUM BONN
NATIONAL UNIVERSITY OF IRELAND GALWAY
Ludwig Boltzmann Gesellschaft - Österreichische Vereinigung zur Förderung der wissenschaftlichen Forschung
BioVariance GmbH
Centre Hospitalier Régional de Marseille - Assistance Publique - Hôpitaux de Marseille
Dysregulated immune responses to infection can result in life-threatening organ dysfunction, known as sepsis or septic shock. Sepsis and septic shock represent a significant burden on healthcare systems, affecting almost 50 million people worldwide every year. Short-term survival from sepsis has improved dramatically in recent years, resulting in increasing numbers of sepsis survivors. Furthermore, sepsis survivors frequently carry a multifactorial burden that can prevent them from regaining their previous state of health. Importantly, 75% of survivors develop complex systemic long-term disorders termed PICS (persistent inflammation, immunosuppression, and catabolism syndrome). Such complex systemic dysregulation frequently persists for months or years and significantly reduces the quality of life (QoL) of sepsis survivors. Although sepsis survivors require detailed medical supervision, current healthcare is inadequate, mainly relying on general practitioners. Moreover, many survivors lack medical supervision altogether, enabling complications to develop unobserved and potentially escalate into serious health issues.
Sustainable Development Goals
Masaryk University is committed to the UN Sustainable Development Goals, which aim to improve the conditions and quality of life on our planet by 2030.